BN
Beroni Group Limited
BNIGF · OTC
$0.01 +0.00% (+$0.00)
Market Cap $295.4K
P/E Ratio -
Div. Yield -
ROE 207.37%
Bulios Fair Price
$0.01
56.3% upside
Current Price
$0.0064
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BNIGF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.93x
P/B 0.08x
P/E N/A
Growth
0 /100
Declining Rev. growth 47.56%
Book val. growth 20.92%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 70.96%
Net margin 3,347.90%
Op. margin 3,871.06%
Quality
1 /100
Poor ROIC 230.74%
ROE 207.37%
ROA 142.41%
Debt
51 /100
Moderate Debt/Equity 0.39x
Current ratio 0.99x
Int. coverage -57.07x
Stability
27 /100
Unstable Beta -1.76x
Rev. volatility 24.07%
EPS volatility 630.33%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BNIGF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Boqing Zhang
Employees
5
Headquarters
Sydney